Department of Medicine, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri, USA.
Clin Infect Dis. 2023 Mar 21;76(6):986-995. doi: 10.1093/cid/ciac879.
Little is known about the clinical and financial consequences of inappropriate antibiotics. We aimed to estimate the comparative risk of adverse drug events and attributable healthcare expenditures associated with inappropriate versus appropriate antibiotic prescriptions for common respiratory infections.
We established a cohort of adults aged 18 to 64 years with an outpatient diagnosis of a bacterial (pharyngitis, sinusitis) or viral respiratory infection (influenza, viral upper respiratory infection, nonsuppurative otitis media, bronchitis) from 1 April 2016 to 30 September 2018 using Merative MarketScan Commercial Database. The exposure was an inappropriate versus appropriate oral antibiotic (ie, non-guideline-recommended vs guideline-recommended antibiotic for bacterial infections; any vs no antibiotic for viral infections). Propensity score-weighted Cox proportional hazards models were used to estimate the association between inappropriate antibiotics and adverse drug events. Two-part models were used to calculate 30-day all-cause attributable healthcare expenditures by infection type.
Among 3 294 598 eligible adults, 43% to 56% received inappropriate antibiotics for bacterial and 7% to 66% for viral infections. Inappropriate antibiotics were associated with increased risk of several adverse drug events, including Clostridioides difficile infection and nausea/vomiting/abdominal pain (hazard ratio, 2.90; 95% confidence interval, 1.31-6.41 and hazard ratio, 1.10; 95% confidence interval, 1.03-1.18, respectively, for pharyngitis). Thirty-day attributable healthcare expenditures were higher among adults who received inappropriate antibiotics for bacterial infections ($18-$67) and variable (-$53 to $49) for viral infections.
Inappropriate antibiotic prescriptions for respiratory infections were associated with increased risks of patient harm and higher healthcare expenditures, justifying a further call to action to implement outpatient antibiotic stewardship programs.
对于不适当使用抗生素的临床和经济后果知之甚少。我们旨在评估常见呼吸道感染中不适当与适当抗生素处方相关的不良药物事件和可归因医疗保健支出的相对风险。
我们使用 Merative MarketScan 商业数据库,于 2016 年 4 月 1 日至 2018 年 9 月 30 日,建立了一个年龄在 18 至 64 岁之间的门诊诊断为细菌(咽炎、鼻窦炎)或病毒性呼吸道感染(流感、病毒性上呼吸道感染、非化脓性中耳炎、支气管炎)的成年人队列。暴露因素为不适当与适当口服抗生素(即细菌感染的非指南推荐与指南推荐抗生素;病毒性感染的任何与无抗生素)。采用倾向评分加权 Cox 比例风险模型估计不适当抗生素与不良药物事件之间的关联。两部分模型用于按感染类型计算 30 天全因可归因医疗保健支出。
在 3294598 名合格成年人中,43%至 56%的人因细菌感染接受了不适当的抗生素治疗,7%至 66%的人因病毒感染接受了不适当的抗生素治疗。不适当的抗生素与多种不良药物事件的风险增加相关,包括艰难梭菌感染和恶心/呕吐/腹痛(风险比,2.90;95%置信区间,1.31-6.41 和风险比,1.10;95%置信区间,1.03-1.18,分别为咽炎)。接受细菌感染不适当抗生素治疗的成年人 30 天的可归因医疗保健支出较高(18 美元至 67 美元),而病毒感染的支出则有所不同(-53 美元至 49 美元)。
呼吸道感染的不适当抗生素处方与患者伤害风险增加和医疗保健支出增加相关,这进一步呼吁采取行动实施门诊抗生素管理计划。